Blog — Infectious Disease

The Last, Best Chance for Global Polio Eradication?

The Last, Best Chance for Global Polio Eradication?

After 25 years of remarkable achievements and sometimes harrowing setbacks, a successful conclusion to global polio eradication could finally be within reach. Every effort should be made to capitalize on this promising moment: if we don't, the opportunity to eradicate polio may slip by.
President’s Malaria Initiative: Big Success from a Quiet Team

President’s Malaria Initiative: Big Success from a Quiet Team

While the giant PEPFAR program to fight HIV/AIDS in developing countries gets a lot of attention in U.S. foreign policy discussions, a lesser known initiative to address malaria is achieving sustained, impressive results. The President’s Malaria Initiative (PMI), launched in 2005 by former President Bush, helps a range of countries prevent and treat malaria by providing them with technical guidance, programmatic support, and funding. Its model and achievements over almost a decade offer important lessons.
Our New iTunesU Course: Global Health Policy in the Second Obama Term

Our New iTunesU Course: Global Health Policy in the Second Obama Term

With the release of our Global Health Policy in the Second Obama Term iTunes University course, we’ve received a few questions about how the course works. This is a quick 101 on the course’s basics.
Global TB Control Through Partnerships

Global TB Control Through Partnerships

On March 21, KNCV honored USAID for the agency’s contribution to the field of global TB control. Dr. Sharon Stash, Senior Fellow and Deputy Director at the Global Health Policy Center, spoke at the awards ceremony and noted options for how the U.S. government can advance these global efforts.
New Institute of Medicine Report on Illegitimate Drugs: A Moral Tragedy

New Institute of Medicine Report on Illegitimate Drugs: A Moral Tragedy

The U.S. Institute of Medicine at the National Academy of Sciences recently released a new report on Countering the Problem of Falsified and Substandard Drugs. Commissioned by the U.S. Food and Drug Administration, it raises important, indeed frightening, concerns about the quality and reliability of medicines in the U.S. and other developed nations, as well as in low- and middle-income countries that often have weaker capacities, and proposes concrete steps in response.
The New State Department Office of Global Health Diplomacy: A Second Chance to Get Things Right

The New State Department Office of Global Health Diplomacy: A Second Chance to Get Things Right

The Office of Global Health Diplomacy offers the Obama administration a second chance, after costly stumbles in the first term, to get its global health policy right, especially in improving cross-agency coherence of U.S. international health programs and sharpening the vision for U.S. leadership in global health.
Global Burden of Disease: New Estimates of What’s Killing Us

Global Burden of Disease: New Estimates of What’s Killing Us

The Seattle-based Institute for Health Metrics and Evaluation (IHME) recently published the most recent global estimates of disease burden that update the leading causes of death and disability across the world, based on data from 2010. It seems a devilishly complicated and ambitious endeavor. While a number of smart people have raised concerns about the reliability of the underlying data, the study report tells a powerful, compelling story about trends in mortality and disability.
The Potential Contribution of the Global Health Service Partnership to Reducing Medical Brain Drain

The Potential Contribution of the Global Health Service Partnership to Reducing Medical Brain Drain

In March 2012, the Peace Corps, the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), and the Global Health Service Corps launched the public-private Global Health Service Partnership, a promising initiative that could improve the health sector in a number of developing countries. The CSIS Global Health Policy Center was fortunate to have the opportunity to play a modest role during the planning stages of this innovative enterprise. As the Partnership moves forward, a number of potential concerns will require careful attention.
The IOM’s PEPFAR Evaluation: Implications for the Global Fund

The IOM’s PEPFAR Evaluation: Implications for the Global Fund

The U.S. Institute of Medicine of the National Academy of Sciences recently completed a congressionally-mandated impact evaluation of the PEPFAR HIV/AIDS program, which is the single largest ever health initiative of the U.S. government. The Global Fund needs to pore over the IOM evaluation and absorb its well-crafted recommendations for achieving even more in the future. Especially in lean economic times, our forward progress in fighting AIDS will depend more than ever on being smart about our approach.
Multimedia: Global Health Policy in Obama’s Second Term

Multimedia: Global Health Policy in Obama’s Second Term

The new volume, Global Health Policy in the Second Obama Term, analyzes seven important dimensions of a complex, widening U.S. global health agenda. Watch the authors discuss their individual topics.
Global Health Policy in the Second Obama Term

Global Health Policy in the Second Obama Term

This new volume from the CSIS Global Health Policy Center, Global Health Policy in the Second Obama Term, analyzes seven important dimensions of a complex, widening U.S. global health agenda: HIV/AIDS; malaria; polio eradication; women’s health; health security; health diplomacy; and multilateral partners.
President Joyce Banda: New Focus on Women’s Health and Empowerment in Malawi

President Joyce Banda: New Focus on Women’s Health and Empowerment in Malawi

CSIS wanted to learn more about how women leaders in Africa are bringing new attention to women’s health and empowerment in their own countries, and to bring those voices into the discussion about U.S. policy priorities for women’s global health. To do this, we sent a small team to Malawi and Zambia in December 2012.

Next Page »